about
Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers.A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical UseSingle Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine ProductionPreclinical Targeted α- and β--Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies
P50
description
researcher
@en
wetenschapper
@nl
name
Quentin Lecocq
@en
Quentin Lecocq
@nl
type
label
Quentin Lecocq
@en
Quentin Lecocq
@nl
prefLabel
Quentin Lecocq
@en
Quentin Lecocq
@nl
P31
P496
0000-0002-2627-0880